A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome**

https://doi.org/10.1016/S0002-9343(96)00017-4Get rights and content

Purpose

To assess possible triggers and cofactors for chronic fatigue syndrome (CFS) and to compare levels of selected cytokines between cases and an appropriately matched control group.

Patients and methods

We Conducted a casecontrol study of 47 cases of CFS obtained through a regional CFS research program maintained at a tertiary care medical center. One age-, gender-, and neighborhood-matched control was identified for each case through systematic community telephone sampling. Standardized questionnaires were administered to cases and controls. Sera were assayed for transforming growth factor-β (TGF-β), interleukin-1β, interleukin-6, tumor necrosis factor-α, and antibody to Borrelia burgdorferi and Babesia microti.

Results

Cases were more likely to have exercised regularly before illness onset than controls (67% versus 40%; matched odds ratio (MOR) = 3.4; 95% Cl = 1.2 to 11.8; P = 0.02). Female cases were more likely to be nulliparous prior to onset of CFS than controls (51% versus 31%; MOR = 8.0; 95% Cl = 1.03 to 170; P = 0.05). History of other major factors, including silicone-gel breast implants (one female case and one female control), pre-morbid history of depression (15% of cases, 11% of controls) and history of allergies (66% of cases, 51% of controls) were similar for cases and controls. However, cases were more likely to have a diagnosis of depression subsequent to their diagnosis of CFS compared to a similar time frame for controls (MOR = undefined; 95% Cl lower bound = 2.5; P < 0.001). Positive antibody titers to B burgdorferi (one case and one control) and B microti (zero cases and two controls) were also similar.

Conclusions

Further investigation into the role of prior routine exercise as a cofactor for CFS is warranted. This study supports the concurrence of CFS and depression, although pre-morbid history of depression was similar for both groups.

References (45)

  • PrietoJ et al.

    Naloxone *reversible monocyte dysfunction in patients with chronic fatigue syndrome

    Scand J Immunol

    (1989)
  • BuchwaldD et al.

    Review of laboratory findings for patients with chronic fatigue syndrome

    Rev Infect Dis

    (1991)
  • GuptaS et al.

    A comprehensive immunological analysis in chronic fatigue syndrome

    Scand J Immunol

    (1991)
  • PatarcaR et al.

    Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression

    Clin Infect Dis

    (1994)
  • KlimasNG et al.

    Immunologic abnormalities in chronic fatigue syndrome

    J Clin Microbiol

    (1990)
  • HolmesGP et al.

    A cluster of patients with a chronic mononudeosis-like syndrome

    JAMA

    (1987)
  • SumayaCV

    Serologic and virologic epidemiology of Epstein-Barr virus: relevance to chronic fatigue syndrome

    Rev Infect Dis

    (1991)
  • StrausSE et al.

    Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection

    Ann Intern Med

    (1985)
  • JonesJF et al.

    Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies

    Ann Intern Med

    (1985)
  • EvansAC

    Brucellosis in the United States

    Am J Public Health

    (1947)
  • CluffLE et al.

    Medical Aspects of delayed convalescence

    Arch Intern Med

    (1959)
  • GowJW et al.

    Studies on enterovirus in patients with chronic fatigue syndrome

    Clin Infect Dis

    (1994)
  • Cited by (77)

    • Chronic Fatigue Syndrome

      2017, Principles and Practice of Pediatric Infectious Diseases
    • Chronic coinfections in patients diagnosed with chronic lyme disease: A systematic review

      2014, American Journal of Medicine
      Citation Excerpt :

      The literature search did not yield evidence of cryptic babesiosis resulting in a less overt syndrome. A study of patients with chronic fatigue syndrome found seroreactivity to Babesia microti in 2 controls but not in any of the study subjects with chronic fatigue.24 A case series of 3 patients attributed panic attacks to infection with multiple tick-borne pathogens including babesiosis.25

    • Chronic fatigue syndrome

      2013, Handbook of Clinical Neurology
      Citation Excerpt :

      A number of retrospective studies investigated the possible role of herpesviruses including Epstein−Barr virus (EBV), cytomegalovirus (CMV), and human herpesvirus 6 (HHV6); enteroviruses − largely Coxsackie B; retroviruses such as human T-cell leukemia virus type 2 (HTLV-2) and the spumaviruses; Borrelia burgdorferi and Borna disease virus. Although some studies reported elevated levels of viral antibodies in groups of CFS patients, the results were inconsistent and there was often considerable overlap between CFS patients and controls (Hotchin et al., 1989; Landay et al., 1991; Kawai and Kawai, 1992; Ablashi, 1994; Levy, 1994; MacDonald et al., 1996). A more definitive large study which tested for antibodies to 13 viruses found that none of these could either discriminate CFS patients from healthy controls, or CFS patients who reported a viral onset from those who did not (Buchwald et al., 1996).

    • Chronic Fatigue Syndrome

      2012, Principles and Practice of Pediatric Infectious Diseases, Fourth Edition
    View all citing articles on Scopus
    **

    Cytokine testing was supported in part through funding from the National Institute of Allergy and Infectious Disease. Antibody testing for Babesia microti was supported in part by Public Health Service grants Al32403, Al-30548, and AR-41497 from the National Institutes of Health and grant U50/CCUS10343 from the Centers for Disease Control and Prevention.

    View full text